Effects of cytotoxic T lymphocytes on hepatoma cell line SMMC-7721 induced by different subsets of dendritic cells in vitro

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 3, 2006, Pages 422-427

  Wang, Jia Xiang ^a   Liu, Guang Hui ^a   Fan, Ying Zhong ^a   Liu, Qiu Liang ^a   Zhou, Juan ^a   Zhang, Dong Yun ^a   Qi, Yuan Ming ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cancer vaccine; Carcinoma, hepatocellular; Dendritic cells; SMMC 7721 cell

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; B7 ANTIGEN; CD1 ANTIGEN; CD83 ANTIGEN; DENDRITIC CELL VACCINE; HLA DR ANTIGEN; INTERLEUKIN 12; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CANCER CELL CULTURE; CELL CULTURE; CELL KILLING; CELL MATURATION; CELL STRUCTURE; CELL SUBPOPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FROZEN SECTION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LIVER CELL CARCINOMA; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD STEM CELL; PHENOTYPE; SUPERNATANT; T LYMPHOCYTE; THAWING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33748082292     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. + cells on human hepatocarcinoma cell line BEL-7402 in vitro and in SCID mice. World J Gastroenterol 2005;11:2502-2507.
2. Deng XH, Weng X, Chen LJ, Ma JQ, Yu JM, Liang H. Specific cell immune response mediated by myeloma lysate pulsed dendritic cells. Shanghai Di-er Yike Daxue Xuebao 2004;24:334-336.
3. Kawachi I, Tanaka K, Tanaka M, Tsuji S. Dendritic cells presenting pyruvate kinase M1/M2 isozyme peptide can induce experimental allergic myositis in BALB/c mice. J Neuroimmunol 2001;117:108-115.
4. Suen JL, Chuang YH, Chiang BL. In vivo tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: the induction of a high level of autoantibodies but not renal pathological changes. Immunology 2002;106:326-335.
5. Burkhard L, Adrian F, Ochsenbein, Bernhard O, Denise P, Hans H, et al. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med 2000;191:795-804.
6. Yang HX, Wang XS, Xu Y. Specific anti-bladder carcinoma response mediated by antigen pulsed dendritic cells. Chin J Exp Surg 2005;22:889-889.
7. Berger CL, Xu AL, Hanlon D, Lee C, Schechner J, Glusac E, et al. Induction of human tumor-loaded dendritic cells. Int J Cancer 2001;91:438-447.
8. Zhou T, Sun GZ, Zhang YM, Zhang YY, Zhang DQ, Tang XM, et al. Effect of interleukin-10 on the phenotype and function of cultured human dendritic cells. Chin Med J 2005;118:1299-1302.
9. Whiteside TL, Odoux C. Dendritic cell biology and cancer therapy. Cancer Immunol Immunother 2004;53:240-248.
10. Akasaki Y, Kikuchi T, Homma S, Abe T, Kofe D, Ohno T. Anti-tumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model. J Immunother 2001;24:106-133.
11. Yu YZ, Cao XT. Role of dendritic cells in immune responses and immune tolerance. Di-er Junyi Daxue Xuebao 2002;10: 2050-2053.
12. Min WP, Zhou D, Ichim TE, Strejan GH, Xia X, Yang J, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003;170:1304-1312.
13. + T Cells. J Immunol 2005;174:7433-7439.
14. Huang CB, Wu J, Zhang GF, Chen XW, He WF. Prolongation of renal allograft survival with tolerogenic dendritic cells loaded with donor antigen in rats. Di-san Junyi Daxue Xubao 2003;25:1906-1908.
15. De Vleeschouwer S, Arredouani M, Ade M, Cadot P, Vermassen E, Ceuppens JL, et al. Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells. Cancer Immunol Immunother 2005;54: 372-382.
16. Li HF, Han CH, Gui XQ, Zhang M, Wang Y, Zhan Ming, et al. Prolongation of the allograft survival by auto-transfusion to recipient of donor dendritic cells pretreated with MMF. Chin J Exp Surg 2005;6:711-714.
17. Gu KJ, Zhang JF. Research of cancer immunotherapy mediated by dendritic cells. Immunol F Med Sci 2005;28: 169-173.
18. Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res 2001;61:6445-6450.
19. Qiu SJ, Ye SL, Tang ZY, Qian SG, Lu LN. The tumor specific anti-tumor effects mounted by hepatoma cell lysates pulsed DC. Chin J Exp Surg 2003;20:797-798.
20. Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, Woerl P, et al. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature cryopreserved peptide-loaded monocyte-derived dendritic cells. J Exp Med 2002;195:1279-1288.
21. O'Rourke MG, Johnson M, Lanagan C, See J, Yang J, Bell JR, et al. Durable complete clinical responses in a phase I / II trial using an autologous melanoma cell/dendritic cell vaccine. Cancer Immunol Immunother 2003;52:387-395.
22. Maier T, Tun-Kyi A, Tassis A, Jungius KP, Burg G, Dummer R, et al. Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumorlysate-pulsed dendritic cells. Blood 2003;102:2338-2344.
23. Kugler A, Stuhler G, Walden P, Zoller G, Zobywalski A, Brossart P, et al. Regression of human metastatic renal cell carcinoma after vaccination with cell-dendritic cell hybrids. Nat Med 2000;6:332-336.
24. Marten A, Flieger D, Renoth S, Weineck S, Albers P, Compes M, et al. Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial. Cancer Immunol Immunother 2002;51:637-644.
25. Chen H, Lou X, Jiang M, Hu LD, Yu ZY, Xu C, et al. Clinical Study on Anti-leukemia effect mediated by dentritic cells. J Exp Hematol 2005;13:412-416.
26. Zeng JY, Li ZY. Immune tolerance. In: Gong FL(ed). Med Immunol, 1st ed. Beijing: Scientific Publishing Company;2000:233.
27. Yang ZZ, Li ZY. Autoimmune and autoimmune disease. In: Gong FL (ed). Med Immunol, 1st ed. Beijing: Scientific Publishing Company;2000:314.
28. Min W, Huang X, Gorczynski R, Cattral M. Fas ligand-transfected dendritic cells induce apoptosis of antigen-specific T cells. Transplant Proc 2001;33:234-241.
29. Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2001;2:585-589.
30. Fallarino F, Asselin-Paturel C, Vacca C, Bianchi R, Gizzi S, Fioretti MC, et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 2004;173:3748-3754.